<HashMap><database>bioimages</database><scores/><additional><omics_type>Unknown</omics_type><submitter/><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-BIAD1834</full_dataset_link><repository>bioimages</repository><figure_sub>Specimen</figure_sub><figure_sub>Study Component</figure_sub><figure_sub>organisation</figure_sub><figure_sub>Biosample</figure_sub><figure_sub>Associations</figure_sub><figure_sub>Image acquisition</figure_sub><pubmed_authors>DANAY CIBRIAN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Restricting SLC7A5-mediated Leucine uptake in T cells prevents acute GVHD and maintains GVT response (EMM-2024-19430)</name><description>The L-Leu amino acid transporter SLC7A5 has become an important target in inflammation and cancer. However, its role in acute graft-versus-host disease (aGVHD) and graft versus tumor (GVT) remains unexplored. We demonstrate that SLC7A5 deletion affected T cell activation, expansion and survival, and reduced IFNγ and granzyme B expression, thus controlling aGVHD, but without effect on tumor growth. On the other hand, dietary restriction of L-Leu reduced aGVHD by controlling T cell expansion, inducing apoptosis, and affecting granzyme B secretion. However, CD8 T cells did not fail to activate and express IFNγ in the absence of L-Leu, and showed an increased proportion of central memory T cells, which contributed to the GVT response. Deletion of SLC7A5 in T cells compromises mTORC1, glycolysi</description><dates><release>2025-04-20T00:00:00Z</release><modification>2026-04-13T15:03:42.101Z</modification><creation>2025-04-15T12:13:13.037Z</creation></dates><accession>S-BIAD1834</accession><cross_references/></HashMap>